Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Proxazole citrate [USAN]
RN: 132-35-4
UNII: YR02IKM54O
InChIKey: WFAULHLDTDDABL-UHFFFAOYSA-N

Classification Codes

  • Analgesic
  • Anti-Inflammatory
  • Drug / Therapeutic Agent
  • Relaxant (Smooth Muscle)

Molecular Formula

  • C17-H25-N3-O.C6-H8-O7

Molecular Weight

  • 479.527
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Proxazole citrate
  • Proxazole citrate [USAN]

Synonyms

  • 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, citrate
  • 3-alpha-Phenylpropyl-5-beta-diethylaminoethyl-1,2,4-oxadiazole citrate
  • 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate
  • 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate (1:1)
  • 5-(2-(Diethylamino)ethyl)-3-(alpha-phenylpropyl)-1,2,4-oxadiazole citrate
  • Aerbron
  • AF-634
  • EINECS 205-059-8
  • Flou
  • N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate
  • NSC 303872
  • Pirecin
  • Propaxolin citrate
  • Propaxoline citrate
  • Proxazole citrate
  • Solacil
  • Toness
  • UNII-YR02IKM54O

Systematic Names

  • 1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate
  • 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • 5-(2-(Diethylammonio)ethyl)-3-(1-phenylpropyl)-1,2,4-oxadiazolediylium citrate

Registry Numbers

CAS Registry Number

  • 132-35-4

FDA UNII

  • YR02IKM54O

System Generated Number

  • 0000132354

Molecular Formulas

Molecular Formula

  • C17-H25-N3-O.C6-H8-O7

Molecular Formula Fragments

  • C17-H25-N3-O
  • C6-H8-O7
  • COMPONENT

Structure Descriptors

InChI

1S/C17H25N3O.C6H8O7/c1-4-15(14-10-8-7-9-11-14)17-18-16(21-19-17)12-13-20(5-2)6-3;7-3(8)1-6(13,5(11)12)2-4(9)10/h7-11,15H,4-6,12-13H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

InChIKey

WFAULHLDTDDABL-UHFFFAOYSA-N

Smiles

c1([C@@H](c2ccccc2)CC)nc(CCN(CC)CC)on1.C(CC(O)=O)(CC(=O)O)(C(=O)O)O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 390mg/kg (390mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.
mouse LD50 intravenous 68mg/kg (68mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.
mouse LD50 oral 1270mg/kg (1270mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.
mouse LD50 subcutaneous 720mg/kg (720mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.
rat LD50 intraperitoneal 390mg/kg (390mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.
rat LD50 oral 1400mg/kg (1400mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 798, 1963.